<style face="normal" font="default" size="100%">Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes</style>

Drupal-Bibcite

31<style face="normal" font="default" size="100%">Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes</style><style face="normal" font="default" size="100%">Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes</style>